Stopping HRT Does Not Accelerate Bone Loss

Published Online: Wednesday, May 1, 2002

Women who stop taking hormone replacement therapy (HRT) may lose bone mineral density (BMD), but their rate of bone loss is similar to that among women who never took HRT, according to data from the Postmenopausal Estrogen/Progestin Intervention Study. As reported in the Archives of Internal Medicine, a total of 495 postmenopausal women were randomized to HRT or placebo and were followed for 7 years.

After treatment cessation, women who took HRT for 1 year had an annual rate of BMD loss of 0.5% at the hip and 0.81% at the spine.

Among women who took HRT for 3 years, this rate was 1.01% at the hip and 1.04% at the spine following treatment cessation. Women who did not take HRT lost about 1% of BMD in the first year of the study and about 0.5% annually thereafter.

Latest Articles
A pharmacy robber not only left his fingerprints behind at a pharmacy—he also dropped his wallet containing his identification as he made his escape.
Janssen Research and Development LLC has submitted a new drug application to the FDA for canagliflozin and metformin hydrochloride extended release (Invokamet XR).
Treating chronic pulmonary obstructive disease with both inhaled corticosteroids and long-acting bronchodilators remains controversial, but new evidence suggests that this controller combination could reduce mortality risk.
Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, shares some fun tips on how to encourage patients who travel to come to your pharmacy for supplies.
Latest Issues